Radiation Safety Committee Radioactive Drug Research Committee
Chair: William Moore
The Radiation Safety Committee is responsible for policies and practices regarding the use of radioactive materials and radiation producing machines; to review all license applications and human use research protocols using radioisotopes or radiation producing machines for research purposes only. The Committee also conducts and reviews the Radiation Protection Program for the Broad Scope Radioactive Material License.
| Meeting | Due Date* |
| September 14, 2009 | August 31, 2009 |
| November 9, 2009 | October 26, 2009 |
| January 11, 2010 | December 28, 2009 |
| March 8, 2010 | February 22, 2010 |
| May 10, 2010 | April 26, 2010 |
| July 12, 2010 | June 28, 2010 |
*All submissions must be received by 5:00 P.M. on the due date. Eighteen copies must be submitted at that time. The due date is in regards to submissions still requiring a grant submission and will require 18 copies. If you need immediate approval for IRB purposes, please send an electronic version and one hard copy version to Jennifer Watson, RSO. Expedited review can be achieved prior to the next Radiation Safety Committee meeting on a case by case basis.
Requirements for Non Human Use:
Requirements for Human Use Research
- A Human Use Research Signature Assurance Sheet
- B Human Use Research General Information Sheet
- B-2 Human Use Research Study Personnel List
- D Consent Form
- C Human Use Research Description
- Q Radiation Worksheet
- Copy of protocol independent of the IRB submission
- Memo outlining Standard of Care versus Research Procedures
Requirements for Human Use - Clinical:
Chair: Darlene Metter, MD
The Radioactive Drug Research Committee is a joint committee for UT Health Science Center at San Antonio, the Veterans Health Care System, Audie L. Murphy Division and the University Health System with a charge to review all protocols involving the use of research radioactive drugs and/or agents with human subjects. Responsible for ensuring compliance of regulations mandated by the US Food and Drug Administration.
Dates through August 2010 –
| Meeting Date | Due Date* |
| September 3, 2009 | August 6, 2009 |
| December 3, 2009 | November 5, 2009 |
| March 4, 2010 | February 4, 2010 |
| June 3, 2010 | May 6, 2010 |
*All submissions must be received by 5:00 P.M. on the due date. Twelve copies must be submitted at that time.
Requirements for Human Use Research:
- A Human Use Research Signature Assurance Sheet
- B Human Use Research General Information Sheet
- B-2 Human Use Research Study Personnel List
- D Consent Form
- C Human Use Research Description
- Q Radiation Worksheet
- Four page application for human use research
- Copy of protocol independent of the IRB submission
- Memo outlining Standard of Care versus Research Procedures
Requirements for Human Use - Clinical: